The Beauty Health Company (NASDAQ:SKIN) – Jefferies Financial Group reduced their Q2 2022 earnings per share estimates for shares of Beauty Health in a report released on Thursday, January 27th. Jefferies Financial Group analyst S. Wissink now anticipates that the company will earn $0.00 per share for the quarter, down from their previous estimate of $0.02. Jefferies Financial Group also issued estimates for Beauty Health’s Q3 2022 earnings at $0.00 EPS, Q4 2022 earnings at $0.01 EPS, Q1 2023 earnings at $0.00 EPS and FY2023 earnings at $0.13 EPS.

Beauty Health (NASDAQ:SKIN) last posted its earnings results on Monday, November 8th. The company reported ($1.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($1.60). The business had revenue of $68.15 million during the quarter, compared to analysts’ expectations of $59.57 million.

A number of other research firms have also recently issued reports on SKIN. William Blair started coverage on Beauty Health in a research note on Friday, January 7th. They issued an “outperform” rating for the company. Stifel Nicolaus started coverage on Beauty Health in a research report on Thursday, October 7th. They set a “buy” rating and a $33.00 price objective for the company. DA Davidson upped their price objective on Beauty Health from $26.00 to $32.00 and gave the stock a “buy” rating in a research report on Wednesday, November 10th. Zacks Investment Research cut Beauty Health from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Raymond James began coverage on Beauty Health in a research report on Thursday, December 23rd. They set a “market perform” rating for the company. Two equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Beauty Health currently has an average rating of “Buy” and a consensus target price of $28.22.

NASDAQ:SKIN opened at $12.48 on Friday. Beauty Health has a 1 year low of $9.71 and a 1 year high of $30.17. The stock has a 50-day moving average price of $21.28 and a two-hundred day moving average price of $23.20.

Hedge funds have recently bought and sold shares of the business. FMR LLC purchased a new stake in Beauty Health during the 2nd quarter valued at $308,817,000. Vanguard Group Inc. purchased a new stake in shares of Beauty Health during the second quarter valued at about $119,177,000. Redmile Group LLC bought a new position in shares of Beauty Health during the 2nd quarter worth approximately $106,735,000. Marshall Wace LLP purchased a new stake in Beauty Health during the third quarter valued at approximately $106,826,000. Finally, BlackRock Inc. lifted its position in Beauty Health by 117.8% during the third quarter. BlackRock Inc. now owns 7,526,320 shares of the company’s stock valued at $195,459,000 after acquiring an additional 4,071,277 shares during the last quarter. Institutional investors and hedge funds own 62.08% of the company’s stock.

Beauty Health Company Profile

Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems.

Read More: Hedge Funds – Risk or Reward?